Targeting of DDR1 with antibody‐drug conjugates has antitumor effects in a mouse model of colon carcinoma-Reference-Cited by-同舟云学术

Targeting of DDR1 with antibody‐drug conjugates has antitumor effects in a mouse model of colon carcinoma

Published:2019-07-22 Issue:9 Volume:13 Page:1855-1873
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Mol Oncol

Author:

Tao Yiran¹,Wang Ruixue¹,Lai Qinhuai¹,Wu Mengdan¹,Wang Yuxi²,Jiang Xiaohua¹,Zeng Lishi¹,Zhou Shijie¹,Li Zhongping¹,Yang Tinghan¹³,Yao Yuqin⁴,Wu Yangping¹⁵,Yu Lin¹⁶,Fu Yuyin¹,Lai Weirong¹,Peng Yujia¹,Lu Ying¹,Zhang Zhixiong¹,Guo Cuiyu¹,Zhang Guangbing¹,Gou Lantu¹,Yang Jinliang¹⁷

Affiliation:

1. State Key Laboratory of Biotherapy and Cancer Center/Collaborative Innovation Center for Biotherapy West China Hospital Sichuan University Chengdu China

2. Department of Respiratory and Critical Care Medicine West China Hospital Sichuan University Chengdu China

3. Department of Gastrointestinal Surgery West China Hospital Sichuan University Chengdu China

4. West China School of Public Health and Healthy Food Evaluation Research Center/No. 4 West China Teaching Hospital Sichuan University Chengdu China

5. Department of Clinical Research Management West China Hospital Sichuan University Chengdu China

6. Department of Clinical Laboratory Mianyang Central Hospital Mianyang China

7. Guangdong Zhongsheng Pharmaceutical Co., Ltd. Dongguan China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.12520

Reference57 articles.

1. Exploring the Collagen-binding Site of the DDR1 Tyrosine Kinase Receptor

2. Inhibition of Discoidin Domain Receptor 1 Reduces Collagen-mediated Tumorigenicity in Pancreatic Ductal Adenocarcinoma

3. Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma

4. FDA Approval: Ado-Trastuzumab Emtansine for the Treatment of Patients with HER2-Positive Metastatic Breast Cancer

5. Tailored Treatment of Colorectal Cancer: Surgical, Molecular, and Genetic Considerations

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of DDR1 promotes ferroptosis and overcomes gefitinib resistance in non-small cell lung cancer;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-10

2. Synergistic approach to combating triple-negative breast cancer: ddr1-targeted antibody-drug conjugate combined with pembrolizumab;Journal of Pharmaceutical Analysis;2024-09

3. Antibody-drug conjugates targeting DDR1 as a novel strategy for treatment of breast cancer;Journal of Drug Targeting;2024-08-09

4. Multiple aspects of matrix stiffness in cancer progression;Frontiers in Oncology;2024-07-02

5. DDR1-targeted therapies: current limitations and future potential;Drug Discovery Today;2024-05